SII Gets DCGI Permission To Manufacture Its Coronavirus Vaccine ‘Covishield’
New Delhi: The Drugs Controller General of India (DCGI) on Monday granted permission to Serum Institute of India (SII) to manufacture its COVID-19 vaccine 'Covishield'.
As per reports, the DCGI has also asked Bharat Biotech to submit…